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B 1.1
INTERMITTENT CLAUDICATION
Introduction and Characterization of Patients
Definition and Nomenclature for Intermittent Claudication
The word claudication is derived from "claudicatio," meaning " to limp." It is said to have origi-
nated when physiologists, studying arterial pressure by cannulating the femoral arteries of horses
and then ligating their femoral arteries, observed them to limp before stopping intermittently, as
they ran in the fields afterwards. The term intermittent claudication has thus come to mean leg
pain sufficient to cause the patient to stop, which is produced by exercise and relieved by rest,
and is caused by arterial occlusive disease. It could be added that the pain is reproducibly caused
by a given degree of exercise and relieved within minutes by rest. These and other characteristics
are discussed further under B 2.1, Clinical Evaluation (p S56) One who claudicates is called a
claudicaru, although the term claudicator is also frequently used. Other diseases that cause dis-
comfort with ambulation have been referred to as claudication, as in neurospinal claudication,
which is discussed later, but these conditions should either be grouped under pseudoclaudica-
tion or be preceded by a defining word such as neurospinal. When intermittent precedes the
word claudication, the cause is presumed to be arterial occlusive in origin, although the simpler
term claudication is mostly used throughout this text.
B 1.1.1 Patient Characteristics
Intermittent claudication (Ie) can be caused by any occlusive lesion in the arterial supply of the
leg muscles that interferes sufficiently enough with blood flow to produce ischemic pain with
exercise. In the Western world at least, it is overwhelmingly the result of atherosclerosis and the
focus of this document, PAD. Other causes are discussed later under differential diagnosis (see B
2.1.2, P 857). Those with IC from PAD will be predominantly older patients, predominantly
male, and almost invariably with identifiable risk factors for atherosclerosis, as previously detailed
in A 2.2, Epidemiology-Intermittent Claudication (p 55).
Also detailed earlier (Epidemiology, A 2.4 and A 2.5, pp 515 and p S18) are the facts that, in
contrast to patients with chronic critical limb ischemia, those with IC tend to have single rather
than multi-level disease, to be somewhat younger, to have less atherosclerotic disease elsewhere,
and a better longevity outlook (in terms of remaining years, not age at death). They also have a
much more benign outlook for future limb loss . These characteristics should be kept in mind in
reading the subsequent sections. It also should be remembered that IC depends on activity
level. Those with arthritis and other conditions preventing ambulation and otherwise sedentary
patients with arterial occlusive disease equivalent to that producing IC in active patients may be
completely asymptomatic in this regard .
B 1.1.2 Hemodynamic Abnormalities
The pathophysiology of PAD, whether it produces claudication, rest pain, or tissue loss, is pri-
marily accounted for by the hemodynamic severity and number of occlusive lesions in the
peripheral circulation. Hemodynamic significance of an arterial stenosis is a function not only of
the percentage stenosis, but also of flow velocity across the Iesion.l,2 For example, at rest, blood
flow velocity in the femoral artery may be as low as 20 crny's, At this velocity, a stenosis will not
become hemodynamically significant until it is 90% occlusive. Above 90% stenosis, flow and
pressure rapidly decrease with increasing obstruction. However, with exercise in the normal
extremity, flow velocity may increase to as high as 150 cmy's, At these higher flow velocities, a
stenosis becomes hemodynamically significant at approximately 50%. Thus, patients with claudi-
cation have normal flow to skeletal muscle at rest, but markedly impaired flow to meet metabol-
ic demand with exercise.
On average, patients with single-segment disease, such as occlusion of the iliac vessels, and good
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collateral development will have mild claudication. With more extensive disease, claudication
symptoms become more severe. Symptoms cannot be entirely explained by the severity of
reduction in blood pressure. For example, the ABPI in patients with claudication is not well cor-
related with their exercise performance on a treadmill, or with the severity of symptoms in the
community setting.3,4,5
B 1.1.3 Metabolic and Neurological Abnormalities
Peripheral arterial disease is not simply a hemodynamic disorder. Additional factors are involved
in the pathogenesis of this disease. Key factors include deconditioning, because these patients
are very inactive. In addition, several studies have shown skeletal muscle injury in patients with
chronic arterial occlusive disease. This injury has been characterized as a distal axonal denerva-
tion leading to loss of muscle fibers and mild atrophy of the affected rnuscle.v-? Muscle strength
is reduced in these patients, which leads to a compromise of muscle function and exercise per-
formance. In addition, oxidative metabolism is severely impaired in PAD patients, and these
changes cannot be accounted for simply by the reduction in blood flow.
Several studies have observed that patients with peripheral arterial disease accumulate intermedi-
ates of oxidation such as acylcarnitines.f These compounds are formed from acyl-Cox interme-
diates in the oxidation of fatty acids, proteins, and carbohydrates. This accumulation has func-
tional significance in that patients with the greatest degree of metabolic disruption and accumu-
lation of acylcarnitines have the most severely impaired exercise performance. Further evidence
for altered metabolism comes from magnetic resonance spectroscopy. Several studies have indi-
cated that patients with PAD have not only impaired resynthesis of phosphocreatinine, but
abnormally high levels of adenosine diphosphate (ADP).9,10 These findings are consistent with a
metabolic myopathy, which occurs in chronic forms of the disease.
In summary, the pathogenesis of PAD is initiated by atherosclerotic occlusions of the major con-
duit vessels in the lower extremity. However, over time the disease affects the skeletal muscle
neurological and metabolic function, leading to further impairments in muscle performance and
patient functional status.
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